首页> 外文期刊>Viral immunology >Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these.
【24h】

Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these.

机译:重组腺病毒载体疫苗比重组痘苗病毒载体,质粒DNA或它们的组合诱导更强的细胞毒性T细胞反应。

获取原文
获取原文并翻译 | 示例
       

摘要

The efficiency of prime-boost vaccinations on the induction of T-cell responses to Sin Nombre virus nucleocapsid protein expressed by recombinant vaccinia virus, replication-deficient adenovirus, and plasmid DNA in mice was quantitated by the number of epitope-specific interferon-gamma-producing T cells and cytotoxic T-lymphocyte activity induced. In prime-boost immunizations, all combinations that included the recombinant adenovirus induced a much higher number of epitope-specific interferon-gamma-producing T cells than did other combinations. A single immunization of the recombinant adenovirus was able to induce similarly high levels of epitope-specific interferon-gamma-producing cells, despite the fact that the recombinant adenovirus produces less amount of the Sin Nombre virus nucleocapsid protein.
机译:初免-加强免疫对重组痘苗病毒,复制缺陷型腺病毒和小鼠质粒DNA表​​达的Sin Nombre病毒核衣壳蛋白诱导T细胞反应的效率通过表位特异性干扰素-γ-的数量进行定量产生T细胞并诱导细胞毒性T淋巴细胞活性。在初免-加强免疫中,包括重组腺病毒在内的所有组合均比其他组合诱导出更高数量的表位特异性干扰素-γ产生性T细胞。尽管重组腺病毒产生较少量的Sin Nombre病毒核衣壳蛋白的事实,但是对重组腺病毒的单次免疫能够诱导相似高水平的表位特异性干扰素-γ-产生细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号